---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-272533"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:41:13.831839+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma stockholders elect directors and approve preferred stock authorization at 2024 annual meeting

## Summary
- Directors J. Kevin Buchi and Peter Francis elected with 17.3M and 16.5M votes respectively.
- Ratification of independent auditor passed with 17,978,704 votes for, 260 against.
- Advisory vote on executive compensation approved with 17,307,680 votes for.
- Amendment to authorize up to 5,000,000 shares of preferred stock approved with 15,313,718 votes for (85% of votes cast).

## SEC filing metadata
- accession: 0001193125-24-272533
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524272533/0001193125-24-272533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524272533/d540210d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-272533
- JSON: https://secwatch.observer/filing/0001193125-24-272533.json
- Plain text: https://secwatch.observer/filing/0001193125-24-272533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.